Microtia is a congenital anomaly, characterized by a small, abnormally shaped auricle (pinna). It is usually accompanied by a narrow, blocked or absent ear canal. Microtia can occur as the only clinical abnormality or as part of a syndrome. The estimated prevalence of microtia is 0.8-4.2/10,000 births and it is more common in males. Microtia can have a genetic or environmental predisposition. Mendelian hereditary forms of microtia with an autosomal dominant or recessive mode of inheritance as well as forms due to chromosomal aberrations have been reported. Several responsible genes have been identified, most of them being homeobox genes. Mouse models have been very useful to study these genes, providing valuable information on the development of the auditory system. In this article, we review the epidemiological characteristics of microtia, and the environmental causes involved. In addition, we discuss the development of the auditory system, specifically on relevant aspects of external and middle ear development. The focus of this review is to discuss the genetic aspects of microtia and associated syndromes. The clinical aspects of different disorders involving microtia are also discussed in relation to the genes that are causing them.
Introduction
The external ear consists of the auricle and the external ear canal. There is a wide range of external ear abnormalities which are related to the size, shape, position of the ear or even the presence of preauricular pits or tags 1 . The main focus of this paper is on microtia.
Microtia (MIM 600674, MIM 251800) is a developmental malformation of the external ear, characterized by a small, abnormally shaped auricle. The prevalence of microtia has been reported to vary between 0.8-17.4/10,000 in different populations [2] [3] [4] [5] [6] [7] (Table 1) . Microtia can occur unilaterally or bilaterally. The unilateral form is much more common, occurring in 79-93% of cases 2, 3, 8 . In unilateral microtia the right ear is more frequently affected (approximately 60% of the unilateral cases) 4, 5, 9 .
3 Individuals with unilateral microtia usually have normal hearing in the other ear. Therefore, speech and language development are usually normal, although these children are at a greater risk of delayed language development and attention deficit disorders 10 . Microtia is more common in males than females with a sex ratio of 1.5 5, 9 . Only in a study in China, there was no different gender distribution 11 .
Microtia is associated with atresia (MIM 607842) (absence or closing) or stenosis (narrowing) of the ear canal in 55-93% of patients 6, 9, 12 . The general characteristics of microtia in different populations are summarized in Table 1 .
There are several grading systems for microtia. In the Marx classification 13 , all of the features of a normal auricle are present in grade I, but the pinna is smaller than normal. In grade II, some anatomical structures are still recognizable. In the most common form, grade III (the peanut-shell type), only a rudiment of soft tissue is present 9 . The extreme case where there is no external ear and auditory canal is called anotia (MIM 600674) or microtia grade IV. The prevalence of anotia has been reported to vary between 5 and 22% of microtia cases 14 . Figure 1 presents ears with grades I to IV of microtia. There is a strong correlation between the degree of microtia and the frequency and severity of middle ear dysplasia. In general, the better developed the external ear, the better developed the middle ear 15, 16 .
In the clinical assessment of a patient with microtia, looking for associated anomalies is important as, if present, attributing them to a known syndrome could be crucial. Otological and audiological evaluation and sometimes radiological imaging should also be considered. More than 80% of microtia patients have aural atresia resulting in conductive hearing loss with air-conduction hearing typically reduced by dB, whereas bone conduction is normal in more than 90% of the affected ears 6, [17] [18] [19] . Genetic counseling should always be considered for a patient with microtia. If auricular reconstruction is indicated, a multistep earlobe reconstruction with autogenous rib cartilage can be applied in most cases 20 . 21 .
Rhombomeres are embryonic territories arising from the transient segmentation of the hindbrain [23] [24] [25] .
Homeobox genes express critical developmental transcription factors in embryonic development. A large group of homeobox genes are Hox genes. The NCCs populating the second branchial arch express HoxA2 (MIM 604685) over a prolonged period 26 . In the absence of normal HoxA2, the boundary between rhombomeres 1 and 2 is lost [27] [28] [29] . This result indicates that HoxA2 is a key transcription factor during development of the second branchial arch that has a main contribution in development of the external and middle ear. The Hoxa2 knockout mouse has provided an appropriate tool to understand the mechanism of development of the auditory system, mainly the outer and middle ear 23, 24, 29 . In these 6 mice, the transformation of some elements of the jaw, as well as of occipital and middle ear bones, has been found. A duplicated set of skeletal elements derived from the first arch neural crest cells is also present in the Hoxa2 knockout, including ectopic incus, malleus and tympanic bones 29 . The second branchial arch also forms a portion of the otic capsule. Parts of the cartilaginous otic capsule were also affected in Hoxa2 knockout mice. Hoxa2 affects the patterning of the tympanic ring and gonial bone and synergizes with Hoxa1 in controlling the growth of these structures 30 . In addition to Hoxa2, Hoxa1 is also important for the development of the external ear in the mouse. The Hoxa1 knockout mouse indicated that inactivation of Hoxa1 results in a complete or near complete deletion of rhombomere 5
and a severe reduction of rhombomere 4, suggesting that Hoxa1 is acting in generation of hindbrain segments [31] [32] [33] .
PACT (MIM 603424) is another important protein involved in the development of auditory system.
PACT (also called Rax) is expressed in the pinna, middle ear and cochlea 34 . To investigate the role of PACT in the development of the auditory system, the murine counterpart for the human PACT was disrupted. The Pact knockout mice were smaller in size than wild-type, exhibited hearing defects, and showed reduction in the size of the outer ear and external auditory canals. In this mouse model, the rostrum was rounded and the nose shortened. Ossicles were malformed and the middle ear space and bulla were very small 34 . In contrast to the defects of the outer and middle ear, the cochlea of the Pact knockout mice was normal.
The embryological origin of the inner ear is different compared to the middle and outer ear, which largely share a common origin. The inner ear derives almost entirely from a small patch of ectodermal cells, termed the otic vesicle (otic placode), through a series of signaling interactions with the adjacent hindbrain and underlying mesenchyme. The otic placode appears on either side of the head at the level of the future hindbrain. During the fourth week, the otic vesicle differentiates into three parts: a dorsal endolymphatic duct and sac, an expanded central utricle and a ventral saccule. From the 4-7 th week, the utricle differentiates to form the three semicircular ducts and the ventral end of the saccule elongates and coils to form the cochlea.
Tbx1 gene expression in the PA I has a critical role in the formation of outer and middle ear. Tbx1 homozygous mutant mice fail in middle and outer ear development. Tbx1 also plays a role in the otic vesicle, resulting in the failure of inner ear sensory organ formation in knockout mice. Tbx1 is required for sensory organ development and for suppression of neural cell fate determination in the otic vesicle 35 .
The human TBX1 (MIM 602054) gene is deleted in DiGeorge syndrome 36 .
Environmental predisposition and microtia: Although the etiology of microtia is poorly understood, both environmental and genetic factors have been implicated. There are many risk factors for microtia, such as gestosis, anemia, race 4, 8 , high maternal or paternal age 2-4 and multiple births 3, 8 . In a clinical analysis of 592 patients with microtia in Japan, 28% of the patients' mothers had a cold, imminent abortion, gestosis or anemia during their pregnancy 9 . Maternal acute illness, such as influenza, during first trimester of pregnancy was the major risk factor for microtia in Latin America 37 . Mothers with chronic type I diabetes are at significantly higher risk for having a child with microtia. Microtia children usually have normal birth weight, but low weight birth is more common than in healthy children 14, 38 .
Certain medications such as isotretinoin, a widely used dermatologic drug, or mycophenolate mofetil (MMF) taken by the mother during pregnancy have also been implicated as microtia-predisposing factors. 83% of pregnancies with isotretinoin exposure result in spontaneous abortion or infants with serious birth defects including microtia 39 . MMF is an immunosuppressive agent, prescribed after solid organ transplantation. Patients who take MMF as immunosuppressive therapy during pregnancy are at risk for having a child with birth defects including microtia and cleft lip and palate 40 .
Microtia-inducing factors have also been found in experimental studies in animals. Ethane dimethane sulfonate (EDS) is an alkylating agent. All offspring of CD-1 mice exposed to EDS during the second half of gestation exhibited a bilateral, dose-related decrease in pinna size 41 . Vitamin A (retinol) is necessary for cell growth and differentiation. Excess vitamin A has been associated with teratogenic effects in animals and humans. Facial clefts, micrognatia, microtia and blood vessel anomalies were seen in the offspring of pregnant rats that were administered etretinate (a synthetic retinoid) 42 .
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Genetics of microtia:
Although there is strong evidence confirming the importance of environmental causes for microtia, it is believed that genetic components are also involved 43 . Estimates on the percentage of familial cases among microtia cases vary widely, ranging from 3-34% 2, 5, 9, 12, 44 (Table 1) . This patient had multiple congenital abnormalities including microtia/anotia, micrencephaly, congenital heart disease, and colonic agangliosis 54 .
A family with an autosomal dominant syndrome characterized by microtia grade II, eye coloboma and imperforation of the nasolacrimal duct was reported 52 . Array-CGH analysis showed that all affected family members had an alteration at 4p consisting of five tandem copies of an identical CNV 52 .
Microtia and lacrimal-duct anomalies have never been observed in patients with partial 4p deletions, duplications or translocations 55 . The exact mechanism by which the CNV causes the syndrome could not be clarified.
Congenital aural atresia occurs in approximately 66% of all patients who have a terminal deletion 18q.
The extent and nature of the chromosome 18 deletions has been studied by array-CGH. A critical region 9 of 5 Mb that was deleted in all patients with congenital aural atresia has been identified on 18q22.3-18q23. This chromosomal region can be considered as a candidate region for aural atresia 56 .
Isolated microtia and Oculo-auriculo-vertebral spectrum: Oculo-auriculo-vertebral spectrum (OAVs) is a heterogeneous disorder involving the first and second branchial arch derivatives. The spectrum of OAVs is broad, ranging from isolated microtia 57 to Goldenhar syndrome (GS) (MIM 164210) characterized by hemifacial microsomia (HFM) (MIM 164210), ocular abnormalities and vertebral defects. Hemifacial microsomia is a congenital asymmetry of the lower face that is defined as a condition affecting primarily aural, oral and mandibular development 58 . Additional characteristics, including developmental delay, cardiovascular pulmonary and gastrointestinal malformations can also be found in patients with OAVs. In Turkish patients with GS, microtia was seen in 52% of patients 59 .
Genetics of OAV including HFM and GS: BAPX1 belongs to the NK-2 family of transcription factors 60 . Bapx1 has an important role in regulating the development of the structural elements of the middle ear in mice. The BAPX1 (MIM 602183) gene plays an essential role in craniofacial development. A strong allelic expression imbalance of BAPX1 in fibroblasts from 40% of patients with OAV syndrome was identified 61 . These data suggests that epigenetic dysregulation of BAPX1 plays an important role in this syndrome in human 61 .
Human Goosecoid (GSC) is a homeodomain transcription factor. It plays an essential role during the process of gastrulation in early embryonic development 62 . Expression of Bapx1 during mouse embryonic development at day E10 partially overlaps with Gsc expression. This overlapping expression is crucial for patterning the structural components of the middle ear 63 . Mice with a homozygous disruption of gsc revealed multiple developmental defects affecting the lower mandible as well as components of the inner ear and the external auditory meatus 64 . A suggestive linkage to a region on chromosome 14q32 was found by genome wide linkage analysis in 2 families with features of HFM 65 .
The most interesting candidate gene in the linked region was GSC. No disease-causing mutation in the coding region and no possible rearrangement of the gene analyzed by Southern blotting could be identified in these 2 families segregating HFM and in 120 sporadic cases of HFM 65 .
The 69 .
Syndromic microtia
15-60% of patients with microtia have additional abnormalities 2, 8, 10, 14 . The associated malformations are more common in the bilateral cases. The most common accompanying dysmorphic features are facial cleft, facial asymmetry, renal abnormalities, cardiac defects, microphtalmia, polydactyly and vertebral anomalies 4, 14, 70 . For some of the microtia-associated syndromes the developmental defects are known, often up to the molecular level. We tried to classify these syndromes based on the defects or mechanisms involved and describe in brief some of the most frequent syndromes or syndromes with a known molecular basis.
Disorders due to abnormalities in branchial arch development HOXA1 deficiency: An autosomal recessive syndrome (MIM 601536) has been found in 4 Saudi
Arabian families and one Turkish family 71 . It was characterized by congenital horizontal gaze abnormalities, delayed motor milestones, cardiac problems, autism, profound sensorineural hearing impairment and external ear defects 71 . The external ear defects included low-set ears and a flattened ear helix 71, 72 . Homozygous pathogenic variants in HOXA1 (MIM 142955) were found in all 5 families studied. This indicates that a mutation in HOXA1 disrupts the inner and outer ear to a variable degree and affects facial, cardiac and brainstem structures 71 . An additional 3 Saudi Arabian and 3 native
American families with HOXA1 mutations provided evidence for a broader clinical spectrum in this disorder and imply that this autosomal recessive syndrome might not be extremely rare 72 . Mice homozygous for a mutation in Hox-1.6 (the homolog for human HOXA1) present hypoplastic auricles, normal auditory meati, a disorganized middle ear and an underdeveloped or even absent inner ear 31, 32 .
In addition, the mice showed defects in specific hindbrain nuclei, ganglia and bones of the skull and die at birth from anoxia 31, 32 .
HOXA2 deficiency: A mutation in the HOXA2 homeobox gene was identified in an Iranian family 17 .
This family was segregating autosomal recessive bilateral microtia (Marx type II), prelingual mixed severe to profound hearing impairment and a partial cleft palate. In a single patient, the cochlea was absent unilaterally. This family shows that abnormal or lost HOXA2 function in human can cause auditory system malformations, including mainly the external and middle ear, but that involvement of the inner ear is also possible Branchio-oto-renal syndrome: Branchio-otic (BO) syndrome is an autosomal dominant developmental disorder characterized by branchial cleft cysts, auricular or external auditory canal abnormalities, 12 preauricular pits and hearing loss. Branchio-oto-renal (BOR) syndrome is diagnosed when BO is accompanied with additional malformations of the kidney or urinary tract 76, 77 . genes are also known to play a role in this genetic complex.
Treacher Collins Syndrome: Treacher Collins Syndrome (TCS) (MIM 154500) is an autosomal dominant disorder of craniofacial development. The major features of the disease include hypoplastic facial bones, microtia or severe malformation of the pinna, micrognathia and other deformities of the external and middle ears, auditory pits, hearing loss, which is conductive in 50-55% of cases, and cleft palate 86, 87 .
Mutations in the TCOF1 (Treacher Collins-Franceschetti 1) gene, have been found as the cause of TCS in up to 78% of patients [88] [89] [90] [91] . Up to now, more than 50 mutations have been identified in the TCOF1 gene, most of them insertions or deletions 88, 92 . TCOF1 encodes a protein called Treacle. Expression 13 studies of Tcof1 in the mouse embryo support a role for this gene in the development of the craniofacial complex and provide further evidence that Treacle is a phosphoprotein that may have a function in nucleolar-cytoplasmic transport. A knockout mouse was made for Tcof1, and the heterozygous mice had severe craniofacial malformations 92 . Tcof1 haploinsufficiency resulted in deficient production of mature ribosomes, leading to reduced cell proliferation and causing a phenotype similar to the characteristics found in TCS 92 . Thus, Treacle is thought to be a regulator of ribosome biogenesis.
DiGeorge deletion syndrome: DiGeorge deletion syndrome (del22q11DS) (MIM 188400) is one of the most common microdeletion chromosomal disorders. In most cases, the deletion eliminates 3Mbp of DNA encoding for approximately 30 genes 93 . The clinical phenotype includes ear defects, hearing impairment, craniofacial abnormalities, thymus and parathyroid gland hypoplasia and heart malformations 94 . Most of the del22q11DS cases have middle and outer ear anomalies, whereas some have inner ear malformations as well 95 . The ears are typically low set, small and with abnormal folding of the pinna. Conductive hearing loss is found in the majority of patients with DiGeorge syndrome 96 .
TBX1 (MIM 602054), a member of the T-box gene family of transcription factors, is deleted in del22q11DS patients. TBX1 is required for ear development and is expressed in multiple tissues during embryogenesis 36 . Although in most cases of DiGeorge syndrome 30 genes are deleted, deletion of TBX1 is sufficient to cause most of the abnormalities observed in del22q11DS.
Nager syndrome: Patients with Nager syndrome (MIM 154400) present micrognathia, external ear defects, external auditory canal stenosis, bilateral conductive hearing loss, cleft palate, downslanting palpebral fissures, a high nasal bridge, hypoplastic or absent thumbs and variable lower limb and toe defects 97 . Most cases of Nager syndrome are sporadic, although both autosomal recessive and dominant familial cases have also been reported 98, 99 .
A double-mutant mouse model was developed for homeobox genes Prx1 (MIM 167420) and Prx2
(MIM 604675), and proved to be an appropriate animal model for studying human acrofacial dysostosis disorders like Nager syndrome. In the double Prx1/Prx2 mutant mice defects in external, middle and inner ear, lack of tympanic rings, cleft mandible and polydactyly were seen 100 . Inactivation of only Prx2 14 in the mouse causes deficiencies in the external, middle and inner ear without any skeletal defects, but the inactivation of both Prx1 and Prx2 genes also results in defects in the craniofacial, skull and vertebral structures 21, 100 . Because of the similarities of the observed phenotype in the Prx1/Prx2 mouse model to those of Nager syndrome, DNA sequencing of 8 patients with Nager syndrome for a possible mutation in either of the PRX1 and PRX2 genes was performed, but no pathogenic variant was found 101 .
FGF signaling defects
FGF3 deficiency: Three unrelated Turkish families with a unique autosomal recessive syndrome were identified 102 . This syndrome was characterized by type I microtia, microdontia and profound congenital deafness associated with a complete absence of inner ear structures bilaterally, with normal-appearing middle ear structures. Three different homozygous mutations in the fibroblast growth factor 3 (FGF3)
(MIM 164950) were the disease-causing variants in these families 102 .
LADD syndrome: The lacrimo-auriculo-dento-digital (LADD) (MIM 149730) syndrome is an autosomal dominant disorder. Besides abnormalities in the 4 structures that constitute the name of the syndrome, sensorineural, conductive, or mixed hearing loss is usually also present 103 . Although the major auricular feature is cup-shaped pinnas 104 , these patients sometimes present bilaterally low-placed, microtic auricles 105 , or hypoplastic auricles and small protruding ears without lobules 106 . LADD syndrome can be caused by heterozygous mutations in the tyrosine kinase domains of the genes encoding fibroblast growth factor receptors 2 (FGFR2) (MIM 176943) , FGFR3 (MIM 134934) or FGF10 (MIM 602115) 103 . These findings are strong evidence for the crucial role of FGF signaling in outer, middle and inner ear development.
Microtia-associated syndromes with other molecular mechanisms CHARGE syndrome:
The term CHARGE represents a non-random association of malformations including coloboma of the retina (C), heart defects (H), atresia of the auditory canal (A), retardation of growth or development (R), genital anomalies (G), and ear abnormalities (E). The incidence of CHARGE syndrome (MIM 214800) has been estimated to range from 0.1 to 1.2/100,000 livebirths 107 .
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The highest incidence of 1/8500 livebirths was reported in Canada 108 . External ear abnormalities and severe hearing loss have been found in all patients with CHARGE syndrome 109 . 124, 125 . Several otologic abnormalities have also been described in KFS, including external ear malformation, ossicular chain abnormalities and structural abnormalities of the inner ear. Hearing impairment is a major feature of KFS and may be sensorineural, conductive or mixed. No characteristic audiometric profile was noted 126 .
Although most cases of KFS are sporadic, both autosomal dominant and autosomal recessive inheritance have been reported 127, 128 . The GDF6 (Growth/Differentiation Factor 6) (MIM 601147) gene was already identified for a spectrum of ocular developmental anomalies 129 , but recently mutations in this gene have been reported in familial and sporadic cases of KFS 130 .
Meier-Gorlin syndrome: Meier-Gorlin syndrome (MGS) (MIM 224690) is an autosomal recessive disorder with microtia, absent patellae, craniofacial anomalies, and delayed skeletal development 131 . It has been suggested that this syndrome is the human equivalent of the short ear mouse model, which carries a mutation in the bmp5 (Bone Morphogenetic Protein 5) gene 132 . Human BMP5 is a member of a subfamily of the bone morphogenetic proteins and a member of the transforming growth factor-beta superfamily of regulatory molecules. It is expressed in condensing mesenchyme, which gives rise to external ear cartilage 133 . However, no BMP5 mutation in human has been reported.
Conclusion
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Microtia is a developmental disorder with an etiology that can be both environmental and genetic.
Several genes that are important in development of the auditory system can be involved, but hard evidence for this involvement is available for only some of the genes. Identification of additional microtia-causing genes will reveal novel information on the molecular mechanisms involved in human craniofacial and ear development. Understanding the genetics of microtia-related syndromes provides tools for appropriate genetic counseling and molecular genetic testing can be helpful to confirm an exact diagnosis. In addition, the creation of mouse models with targeted mutations has provided experimental possibilities to determine the function of these genes in the development of the auditory system. The final goal of all this research is to have a complete cellular and molecular insight into the development of the ear and to have an understanding of the genetics and pathogenesis of different microtia-associated disorders.
